May 9-10, 2012 | The Hub Cira Center, Philadelphia


View Agenda
050912 brochure


Outsourcing Drug Discovery in China

May 10



Beyond R&D: Partnership and Licensing Tactics
Contact Us

info@cypinproduction.com
917.338.7778
Panel Sponsors

Finnegan

woodcock

tee&howe

Industry Partners

BayHelix
BIOCOM

Lead Media Partner

 PI

Media Partners









Greetings!

   

 

Last Chance to Register! 

 

The U.S.-CHINA PHARMA conference taking place on May 9-10 in Philadelphia is just around the corner. We urge all wishing to attend the conference to register as soon as possible.

Don't miss the unique opportunity to meet face-to-face with the industry's movers and shakers who are currently shaping the R&D ecosystem between the U.S. and China. The impressive roaster of high-level executives will discuss the opportunities and challenges for research, development, partnering, licensing, and deals making. There will be plenty of time to meet, greet, and to network during the event, including a speed networking session scheduled on May 9, so please bring enough business cards with you and walk away with partners for your next projects!


Our speaker faculty includes:
  • ABBOTT LABORATORIES, Danchen Gao, Director
  • ABBOTT LABORATORIES, Murali Gopalakrishnan, Head, Global External Research, GPR&D (tentative) 
  • ABBOTT LABORATORIES, Ying Wang, Senior Scientist III
  • AGIOS PHARMACEUTICALS, Shengfang Jin, Head, Strategic Outsourcing
  • ASIA PACIFIC BIO INTELLIGENCE, Seth Goldenberg, President
  • BFC GROUP, David Chen, Managing Director
  • BIOCOM CHINA CONSULTING, David Jiang, Managing Director
  • BRISTOL MYERS SQUIBB, Karen LaRochelle, Executive Director
  • BRISTOL MYERS SQUIBB, Litao Zhang, Executive Director, Lead Evaluation and Mechanistic Biochemistry
  • CRYSTAL PHARMATECH, Robert Wenslow, Vice President, Business Development
  • FINNEGAN, Richard Racine, Partner
  • FOUNTAIN MEDICAL DEVELOPMENT, Joanne Jiang, Co-Founder, VP Business Development and Project Management
  • GENEWIZ, Xuefeng Zhang, Sales Executive
  • LIMR CHEMICAL GENOMICS CENTER (LCGC), Melvin Reichman, Director
  • MERCK & CO., Ruo Xu, Principal Scientist
  • MUSTANG VENTURES, Charles Hsu, Senior Advisor and Venture Partner
  • NINDS/NIH NEUROSCIENCE CENTER, Daofen Chen, Program Director
  • NOVARTIS VACCINES & DIAGNOSTICS, Jeffrey Ulmer, Global Head of External Research
  • O'MELVENY & MYERS, Wenseng "Wendy" Pan, Counsel
  • O'MELVENY & MYERS, Stanton Lovenworth, Counsel
  • PERSONAL DIAGNOSTIX INC., Zhifeng Long, Founder, President, and CEO
  • PFIZER INC., Yuan-Hua Ding, Senior Director & Head of External R&D Innovation - Asia
  • PFIZER INC., Austin Zhang, Senior Corporate Counsel
  • PHARMARON, Katherine Lee, Sr. VP, Business & Partnership Development
  • SHANGHAI FOSUN PHARMACEUTICAL GROUP, Vincent Liu, Chief Representative New York (tentative)
  • SR ONE, Rajeev Dadoo, Partner
  • TEE & HOWE INTELECTUAL PROPERTY ATTORNEYS, James Haynes, Senior Partner
  • UNIVERSITY OF PENNSYLVANIA, Joe Powers, Managing Director, Office of the Vice Provost for Research; Executive Director, Center for Neuroscience & Society 
  • WOODCOCK WASHBURN LLP, Jeffrey Rosedale    
  • WUXI APPTEC, Bill Farley, Director of Business Development

For media requests, more information on Cypin Production, or if you are interested in sponsoring, exhibiting, or speaking opportunities, please contact Judy Tsui at judy@cypinproduction.com or 917.338.7778.  

 

Sincerely,

 


Judy Tsui
Cypin Production LLC